Skip to main content
OpenTrials
Completed

NCT Number: NCT05947227

Effects of BBT Versus Diaphragmatic Breathing on Exercise Capacity and Quality of Life in Patients With COPD

Group A will be treated with manual chest physical therapy and Buteyko breathing technique Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique. Patients will perform the technique 5 times a weeks for 8weeks and treatment evaluation will be done after 8 weeks

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breathing Technique Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

40 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Gulab Devi Hospital, Lahore

Lahore, Punjab Province, Pakistan

About this study

A randomized clinical trial will be conducted at Gulab Devi Hospital, Lahore through convenience sampling technique on 48 patients which will be allocated through simple random sampling through sealed enveloped into group A and group B. Pre-treatment values of patients exercise capacity will be recorded by 6MWT/6MWD- 6 minute walk test/ 6 minutes' walk distance and patients quality of life through St George respiratory questionnaire as primary outcomes while oxygen saturation, heart rate will be measured by pulse oximtery during 6MWT as secondary outcomes. Group A will be treated with manual chest physical therapy and Buteyko breathing technique Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique. Patients will perform the technique 5 times a weeks for 8weeks and treatment evaluation will be done after 8 weeks.

Data will be analyzed using SPSS software version 25.After assessing normality of data by Shapiro-Wilk test , it will be decidedeither parametric or non-parametric test will be used.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age group : 40-65 years
  • Both males and females
  • Clinical diagnosis of COPD confirmed by smoking history and PFT airflow
  • Patients taking their regular medications e.g bronchodilator

Exclusion criteria

  • Restrictive lung disease
  • Pneumothorax
  • Resting O2 saturation <90% with room air breathing
  • Recent exacerbations
  • Patients with active viral or bacterial infection
  • Abdominal or thoracic surgery (<3months ago)
  • Cardiologic conditions (<6months ago e.g Myocardial infarction or unstable angina
  • Intubated Patients
  • Orthopedic or urogenital conditions
  • Neurological disorders limiting cognition & mobility

Treatment and study plan

Buteyko Breathing Technique

Other

Group A : will be treated with manual chest physiotherapy & Buteyko Breathing exercise

Diaphragmatic breathing technique.

Other

Group B : will be treated with manual chest physiotherapy & Diaphragmatic Breathing Treatment evaluation will be done after 8 weeks through 6MWT & St George respiratory Questionnaire. Patients will perform technique 5 times a weeks for 8 weeks

Primary outcomes

  1. 6 Minute Walk Distance

    Time frame: 4 weeks.

    Distance will be measured in meter through 6 minute walk test.

Secondary outcomes

  1. St George Respiratory Questionnaire for quality of life :

    Time frame: 4 weeks.

    St George Respiratory Questionnaire/SGRQ is a well established disease specific for health status in asthma and COPD (26).A total three component scores are provided , symptoms (8 items) , activity (16 items) and impacts (26 items), 50 items vary as likert type scale and dichotomus (true/false). In the symptom component , patients are instructed to recall their symptoms in a specific time frame of 1 month , 3 months or 1 year. Other items are not time specific.Scores ranged from 0 ( no impairment ) to 100 ( worst health status)

Other outcomes

  1. oxygen saturation

    Time frame: 4 weeks

    Oxygen saturation will be measured through pulse oximeter.

  2. heart rate

    Time frame: 4 weeks

    Pulse rate will be measured through pulse oximeter which will be consider as heart rate of the patient.

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Jul 17, 2023
Registry last updated
Jun 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.